The curative potential of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection have transformed hepatology in recent years. However, the challenge of identifying more people living with HCV remains,…
This is the ideal opportunity for you to learn from some of the biggest names in hepatology and meet them in an engaging & interactive setting!
EASL has been actively working to beat liver disease, including NAFLD & NASH, through its schools and key event, the NAFLD Summit. EASL has also developed a Policy Statement on…
Be a part of this innovative and engaging digital event for the liver community to connect and learn via cutting-edge content. Enjoy three days of immersive and lively exchanges at…